Vineet Agarwal, MBA, chief financial officer at Korro Bio, is a seasoned finance professional with over 14 years of Investment banking experience working with innovative biopharma companies.
Prior to joining Korro, Vineet was most recently senior executive director with J.P. Morgan Chase & Co.’s healthcare investment banking group based out of New York. There, he had broad coverage across the life sciences industry, helping companies with mission-critical financings including private placements, initial public offerings (IPOs), special purpose acquisition companies (SPACs), primary and secondary equity follow-on offerings (FOs), convertible equity and debt deals. He was also responsible for advising clients on strategic transactions including acquisitions, mergers and licensing deals, and has worked on transformative M&A deals in the biopharma space.
Vineet began his career with J.P. Morgan in 2007 and has served in numerous leadership roles across different countries.
Vineet earned his MBA from the Institute of Management Technology, India, and bachelor’s degree in finance from Shri Ram College of Commerce (SRCC), India.